KorrekturOpen Access · CC BY-NC 4.0
Correction to: Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study
Modern Rheumatology · 04.11.2026 · 36 (6) · 1067-1067
DOI: 10.1093/mr/roag081 ↗Kurz gefasst
Korrektur in der Zeitschrift Modern Rheumatology, online erschienen am 12.09.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to: Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study. Modern Rheumatology, 36(6), 1067-1067. https://doi.org/10.1093/mr/roag081
Vancouver
Correction to: Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study. Modern Rheumatology. 2026;36(6):1067-1067. doi:10.1093/mr/roag081
BibTeX
@article{euvimed2026,
title = {Correction to: Factors associated with treatment discontinuation and age-stratified safety of abatacept in Japanese patients with rheumatoid arthritis: 5-year results of the ORIGAMI study},
journal = {Modern Rheumatology},
year = {2026},
volume = {36},
number = {6},
pages = {1067--1067},
doi = {10.1093/mr/roag081}
}
EUVIMED